Blood Biomarkers from Research Use to Clinical Practice : What Must Be Done? A Report from the EU/US CTAD Task Force
Citation
Angioni , D , Delrieu , J , Hansson , O , Fillit , H , Aisen , P , Cummings , J , Sims , J R , Braunstein , J B , Sabbagh , M , Bittner , T , Pontecorvo , M , Bozeat , S , Dage , J L , Largent , E , Mattke , S , Correa , O , Gutierrez Robledo , L M , Baldivieso , V , Willis , D R , Atri , A , Bateman , R J , Ousset , P J , Vellas , B , Weiner , M & EU/US/CTAD Task Force 2022 , ' Blood Biomarkers from Research Use to Clinical Practice : What Must Be Done? A Report from the EU/US CTAD Task Force ' , Journal of Prevention of Alzheimer's Disease , vol. 9 , no. 4 , pp. 569-579 . https://doi.org/10.14283/jpad.2022.85
Rights
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.